411 related articles for article (PubMed ID: 17003462)
1. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
2. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
3. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
4. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
5. Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor.
Oshima Y; Deering T; Oshima S; Nambu H; Reddy PS; Kaleko M; Connelly S; Hackett SF; Campochiaro PA
J Cell Physiol; 2004 Jun; 199(3):412-7. PubMed ID: 15095288
[TBL] [Abstract][Full Text] [Related]
6. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
7. Generation of transgenic mice with mild and severe retinal neovascularisation.
Lai CM; Dunlop SA; May LA; Gorbatov M; Brankov M; Shen WY; Binz N; Lai YK; Graham CE; Barry CJ; Constable IJ; Beazley LD; Rakoczy EP
Br J Ophthalmol; 2005 Jul; 89(7):911-6. PubMed ID: 15965177
[TBL] [Abstract][Full Text] [Related]
8. rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.
Lai CM; Estcourt MJ; Wikstrom M; Himbeck RP; Barnett NL; Brankov M; Tee LB; Dunlop SA; Degli-Esposti MA; Rakoczy EP
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4279-87. PubMed ID: 19357358
[TBL] [Abstract][Full Text] [Related]
9. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
10. VEGF-induced choroidal damage in a murine model of retinal neovascularisation.
Tee LB; Penrose MA; O'Shea JE; Lai CM; Rakoczy EP; Dunlop SA
Br J Ophthalmol; 2008 Jun; 92(6):832-8. PubMed ID: 18523088
[TBL] [Abstract][Full Text] [Related]
11. Expression and activation of STAT3 in ischemia-induced retinopathy.
Mechoulam H; Pierce EA
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927
[TBL] [Abstract][Full Text] [Related]
12. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
13. Low power laser treatment of the retina ameliorates neovascularisation in a transgenic mouse model of retinal neovascularisation.
Yu PK; Cringle SJ; McAllister IL; Yu DY
Exp Eye Res; 2009 Nov; 89(5):791-800. PubMed ID: 19615996
[TBL] [Abstract][Full Text] [Related]
14. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
15. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
16. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy.
Ishihama H; Ohbayashi M; Kurosawa N; Kitsukawa T; Matsuura O; Miyake Y; Muramatsu T
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1172-8. PubMed ID: 11328724
[TBL] [Abstract][Full Text] [Related]
17. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
18. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina.
Yamada H; Yamada E; Hackett SF; Ozaki H; Okamoto N; Campochiaro PA
J Cell Physiol; 1999 May; 179(2):149-56. PubMed ID: 10199554
[TBL] [Abstract][Full Text] [Related]
19. [Expression of mRNA of vascular endothelial growth factor in a rat model of hyperoxia-induced retinopathy].
Zhang ZH; Jiang L; Qiao LX
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):371-4. PubMed ID: 17706045
[TBL] [Abstract][Full Text] [Related]
20. Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.
Oshima Y; Oshima S; Nambu H; Kachi S; Takahashi K; Umeda N; Shen J; Dong A; Apte RS; Duh E; Hackett SF; Okoye G; Ishibashi K; Handa J; Melia M; Wiegand S; Yancopoulos G; Zack DJ; Campochiaro PA
FASEB J; 2005 Jun; 19(8):963-5. PubMed ID: 15802489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]